Botox onabotulinumtoxinA regulatory update

FDA approved an sBLA from Allegan for Botox onabotulinumtoxinA to treat chronic migraine. Botox is already approved in the U.S. to treat severe primary axillary hyperhidrosis, cervical dystonia and st...